A carregar...
Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research
Despite all scientific efforts and many protracted and expensive clinical trials, no new drug has been approved by FDA for treatment of Alzheimer disease (AD) since 2003. Indeed, more than 200 investigational programs have failed or have been abandoned in the last decade. The most probable explanati...
Na minha lista:
| Publicado no: | Biomedicines |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966425/ https://ncbi.nlm.nih.gov/pubmed/31835422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines7040097 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|